A-438079 hydrochloride hydrate
SIGMA/A9736 - ≥98% (HPLC)
Synonym: 3-
CAS Number: 899431-18-6
Empirical Formula (Hill Notation): C13H9Cl2N5·HCl · xH2O
Molecular Weight: 342.61 (anhydrous basis)
MDL Number: MFCD17215929
Linear Formula: C13H9Cl2N5·HCl · xH2O
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C13H9Cl2N5.ClH.H2O/c14 |
| InChI key | ZHFJJBAKSROKNO-UHFFFAOYSA |
| originator | Abbott |
| Quality Level | 100 ![]() |
| SMILES string | O.Cl.Clc1cccc(c1Cl)-c2nnn |
| solubility | DMSO: 20 mg/mL, clear |
| storage condition | desiccated |
| storage temp. | 2-8°C |
| Application: | A-438079 hydrochloride hydrate has been used to determine its inhibitory effect on purinergic receptors. It has also been used to check its inhibitory effects on macrophages. |
| Biochem/physiol Actions: | A-438079 hydrochloride hydrate is a selective P2X7 purinoceptor antagonist |
| Biochem/physiol Actions: | A-438079 hydrochloride hydrate is a selective P2X7 purinoceptor antagonist in both human and rat with minimal activity at 75 different G-protein-coupled receptors, enzymes, transporters, and ion channels tested. |
| Features and Benefits: | This compound was developed by Abbott . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

